Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001050 |
---|---|
Receipt number | R000001258 |
Scientific Title | A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07) |
Date of disclosure of the study information | 2008/03/01 |
Last modified on | 2015/08/27 16:13:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/02/24 20:05:16 | ||
2 | Update | 2011/03/06 15:08:51 | Name of person sending information Organization Division name Address |
|
3 | Update | 2011/08/26 17:45:57 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2011/08/26 17:46:48 | Recruitment status |
|
5 | Update | 2012/02/27 15:22:26 | Last follow-up date |
|
6 | Update | 2013/09/07 18:55:44 | Email |
|
7 | Update | 2014/02/24 11:43:03 | Recruitment status |
|
8 | Update | 2015/08/27 16:13:13 | Recruitment status Last follow-up date |